Literature DB >> 29553944

Psychosis in "Cognitively Asymptomatic" Elderly Subjects is Associated With Neuritic Plaque Load, Not Neurofibrillary Tangles.

Julia Kim1,2, Tom A Schweizer1,2,3,4,5, Corinne E Fischer1,2,6, David G Munoz1,7,8.   

Abstract

INTRODUCTION: Despite having severe Alzheimer disease pathology, some individuals remain cognitively asymptomatic (cASYM). To explore noncognitive manifestations in these cASYM individuals, we aim to investigate the prevalence and pathologic substrates of psychosis.
METHODS: Data were obtained from the National Alzheimer's Coordinating Center. The Neuropsychiatric Inventory Questionnaire, quick version was used to evaluate presence of psychosis. Subjects with Mini-Mental Status Examination score of ≥24 with frequent neuritic plaques (NPs) were defined as NPcASYM, and those with Braak and Braak stage of neurofibrillary tangles of V/VI were defined as NTcASYM (both groups collectively designated cASYM). Logistic regression analysis was used to examine the association between NP and neurofibrillary tangle severity and psychosis accounting for potential confounders.
RESULTS: We identified 667 subjects with Mini-Mental Status Examination score of ≥24, of which 137 were NPcASYM and 96 were NTcASYM. NPcASYM were at significantly higher risk of having psychosis compared with those with moderate or sparse/no NP (odds ratio, 2.47; 95% confidence interval, 1.54-3.96). NTcASYM were also at higher risk compared with those with Braak and Braak stage I to IV, but the association explained by the effect of Lewy body pathology and microinfarcts. DISCUSSION: The load of NP may be an important substrate of psychosis in individuals who show no gross cognitive symptoms.

Entities:  

Mesh:

Year:  2018        PMID: 29553944      PMCID: PMC6107422          DOI: 10.1097/WAD.0000000000000250

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  25 in total

1.  Beta amyloid, tau, neuroimaging, and cognition: sequence modeling of biomarkers for Alzheimer's Disease.

Authors:  S Duke Han; Jonathan Gruhl; Laurel Beckett; Hiroko H Dodge; Nikki H Stricker; Sarah Farias; Dan Mungas
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

2.  Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.

Authors:  Corinne E Fischer; Winnie Qian; Tom A Schweizer; Colleen P Millikin; Zahinoor Ismail; Eric E Smith; Lisa M Lix; Paul Shelton; David G Munoz
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

3.  Cool with plaques and tangles.

Authors:  Douglas C Ewbank; Steven E Arnold
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

4.  Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment.

Authors:  Zahinoor Ismail; Eric E Smith; Yonas Geda; David Sultzer; Henry Brodaty; Gwenn Smith; Luis Agüera-Ortiz; Rob Sweet; David Miller; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2015-06-18       Impact factor: 21.566

Review 5.  Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003.

Authors:  Susan A Ropacki; Dilip V Jeste
Journal:  Am J Psychiatry       Date:  2005-11       Impact factor: 18.112

6.  Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Jeremy Koppel; Suzanne Sunday; Terry E Goldberg; Peter Davies; Erica Christen; Blaine S Greenwald
Journal:  Am J Geriatr Psychiatry       Date:  2013-03-15       Impact factor: 4.105

Review 7.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 8.  [Post-mortem diagnosis of Alzheimer's disease].

Authors:  D R Thal; H Braak
Journal:  Pathologe       Date:  2005-05       Impact factor: 1.011

9.  Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia.

Authors:  C Bancher; K Jellinger; H Lassmann; P Fischer; F Leblhuber
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

10.  The natural history of Alzheimer disease: a longitudinal presymptomatic and symptomatic study of a familial cohort.

Authors:  Alison K Godbolt; Lisa Cipolotti; Hilary Watt; Nick C Fox; John C Janssen; Martin N Rossor
Journal:  Arch Neurol       Date:  2004-11
View more
  3 in total

Review 1.  Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer's disease and cognitively unimpaired individuals.

Authors:  Kok Pin Ng; Hui Chiew; Pedro Rosa-Neto; Nagaendran Kandiah; Zahinoor Ismail; Serge Gauthier
Journal:  Transl Neurodegener       Date:  2021-03-31       Impact factor: 8.014

Review 2.  Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions.

Authors:  Luis Agüera-Ortiz; Ganesh M Babulal; Marie-Andrée Bruneau; Byron Creese; Fabrizia D'Antonio; Corinne E Fischer; Jennifer R Gatchel; Zahinoor Ismail; Sanjeev Kumar; William J McGeown; Moyra E Mortby; Nicolas A Nuñez; Fabricio F de Oliveira; Arturo X Pereiro; Ramit Ravona-Springer; Hillary J Rouse; Huali Wang; Krista L Lanctôt
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 3.  Delusion and Delirium in Neurodegenerative Disorders: An Overlooked Relationship?

Authors:  Daniele Urso; Valentina Gnoni; Marco Filardi; Giancarlo Logroscino
Journal:  Front Psychiatry       Date:  2022-01-18       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.